Colossal Biosciences has successfully raised $200 million in funding, achieving a valuation of $10.2 billion, to advance its efforts in de-extinction, specifically focusing on bringing back the woolly mammoth. Ben Lamm, co-founder and CEO of Colossal Biosciences, expressed enthusiasm about the project, stating, "What we’re excited about is that we are solving hard problems." The company has already made progress by creating a prototype known as the 'Woolly Mouse,' marking a significant milestone in their ambitious goal of reintroducing mammoths to the Arctic. The initiative has garnered attention from various sectors, including the Toronto Zoo, which has shown interest in the implications of such de-extinction efforts.